DPH Share Price

Open 1559.00 Change Price %
High 1560.00 1 Day -2.00 -0.13
Low 1553.00 1 Week -4.00 -0.26
Close 1553.00 1 Month 131.00 9.21
Volume 435935 1 Year 477.00 44.33
52 Week High 1582.00
52 Week Low 811.00
DPH Important Levels
Resistance 2 1559.49
Resistance 1 1556.82
Pivot 1555.33
Support 1 1549.19
Support 2 1546.51
LON UK Most Active Stocks
CWC 74.60 0.27%
CWC 74.60 0.27%
CWC 74.60 0.27%
INC 0.04 -20.00%
LGO 0.11 -8.33%
LGO 0.11 -8.33%
LGO 0.11 -8.33%
LLOY 67.11 -0.36%
OTC 0.02 0.00%
OTC 0.02 0.00%
More..
LON UK Top Gainers Stocks
AKT 28.50 5177.78%
HHR 58.00 900.00%
MLD 10.00 700.00%
BAF 89.80 83.27%
BAF 89.80 83.27%
BAF 89.80 83.27%
BAC 24.71 76.50%
BAC 24.71 76.50%
BAC 24.71 76.50%
MES 0.28 75.00%
More..
LON UK Top Losers Stocks
ENDV 0.02 -99.85%
KEA 0.10 -91.30%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
DCP 0.50 -75.61%
PCI 3.50 -53.27%
PCI 3.50 -53.27%
NRRP 4.45 -53.16%
BHR 0.02 -33.33%
More..

Dechra Pharmaceuticals PLC (LON: DPH)

DPH Technical Analysis 5
As on 21st Feb 2017 DPH Share Price closed @ 1553.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1285.19 & Strong Buy for SHORT-TERM with Stoploss of 1400.98 we also expect STOCK to react on Following IMPORTANT LEVELS.
DPH Target for February
1st Target up-side 1542.11
2nd Target up-side 1602.47
3rd Target up-side 1662.82
1st Target down-side 1369.89
2nd Target down-side 1309.53
3rd Target down-side 1249.18
DPH Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.dechra.com
DPH Address
DPH
24 Cheshire Avenue
Cheshire Business Park
Northwich, CW9 7UA
United Kingdom
Phone: 44 1606 814 730
Fax: 44 1606 814 731
DPH Latest News
Dechra Pharmaceuticals plc - Receive News & Ratings Daily   Sports Perspectives   - 28th Jan 17
Panmure Gordon Reiterates “Under Review” Rating for Dechra Pharmaceuticals plc ...   Sports Perspectives   - 27th Jan 17
Dechra® Pharmaceuticals PLC Trading Update   PR Newswire (press release)   - 17th Jan 17
Brokerages Set Dechra Pharmaceuticals plc (DPH) Price Target at $1337.43   Sports Perspectives   - 28th Dec 16
Dechra Pharmaceuticals PLC: Australian Acquisition-Apex Laboratories for A$55m   Marketwired (press release)   - 16th Sep 16
Dechra Pharmaceuticals PLC: Annual Results   PR Newswire (press release)   - 05th Sep 16
Dechra® Pharmaceuticals PLC: Trading Update & Notice of 2016 Annual Results   PR Newswire (press release)   - 12th Jul 16
Dechra Pharmaceuticals PLC, Agrees Acquisition of US-based Putney, Inc for ...   PR Newswire (press release)   - 15th Mar 16
Dechra Pharmaceuticals PLC: Half-Yearly Financial Report 2016   PR Newswire (press release)   - 22nd Feb 16
Dechra® Pharmaceuticals PLC (Dechra or the Group) : Trading Update   PR Newswire (press release)   - 14th Jan 16
Interactive Technical Analysis Chart Dechra Pharmaceuticals PLC ( DPH LON UK )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Dechra Pharmaceuticals PLC
DPH Business Profile
Dechra Pharmaceuticals PLC is engaged in the development, manufacture, distribution, sale, and marketing of veterinary pharmaceuticals worldwide. It markets and sells licensed branded pharmaceuticals and specialist pet foods to the veterinary professionals in Europe, as well as manufactures products for third party customers. The company also markets and sells a range of endocrine, ophthalmic, dermatological, and equine products in North America. In addition, it develops and licenses its branded veterinary product portfolio of novel and generic pharmaceuticals, and specialist pet diets. The company distributes its products through a mixture of its own direct sales, wholesalers, and national distributor channels. Dechra Pharmaceuticals PLC is headquartered in Northwich, the United Kingdom.